These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Unraveling the epigenetic code of cancer for therapy. Smith LT; Otterson GA; Plass C Trends Genet; 2007 Sep; 23(9):449-56. PubMed ID: 17681396 [TBL] [Abstract][Full Text] [Related]
5. Epigenetic opportunities and challenges in cancer. Best JD; Carey N Drug Discov Today; 2010 Jan; 15(1-2):65-70. PubMed ID: 19897050 [TBL] [Abstract][Full Text] [Related]
6. DNA demethylating agents and epigenetic therapy of cancer. Mani S; Herceg Z Adv Genet; 2010; 70():327-40. PubMed ID: 20920754 [TBL] [Abstract][Full Text] [Related]
7. Development and classes of epigenetic drugs for cancer. Dhanak D; Jackson P Biochem Biophys Res Commun; 2014 Dec; 455(1-2):58-69. PubMed ID: 25016182 [TBL] [Abstract][Full Text] [Related]
8. A new paradigm in toxicology and teratology: altering gene activity in the absence of DNA sequence variation. Reamon-Buettner SM; Borlak J Reprod Toxicol; 2007 Jul; 24(1):20-30. PubMed ID: 17596910 [TBL] [Abstract][Full Text] [Related]
9. Epigenetic drugs take on cancer. Kaiser J Science; 2010 Oct; 330(6004):576-8. PubMed ID: 21030620 [No Abstract] [Full Text] [Related]
10. Epigenetic cancer therapy: Proof of concept and remaining challenges. Mund C; Lyko F Bioessays; 2010 Nov; 32(11):949-57. PubMed ID: 21154865 [TBL] [Abstract][Full Text] [Related]
11. Marking off new territory in the search for anticancer compounds: epigenetic mechanisms add complexity and promise to cancer research efforts. Nelson B Cancer Cytopathol; 2012 Jun; 120(3):143-4. PubMed ID: 22692980 [No Abstract] [Full Text] [Related]
12. Zebularine: a candidate for epigenetic cancer therapy. Bradbury J Drug Discov Today; 2004 Nov; 9(21):906-7. PubMed ID: 15501719 [TBL] [Abstract][Full Text] [Related]
13. Epigenetic changes to the MDR1 locus in response to chemotherapeutic drugs. Baker EK; Johnstone RW; Zalcberg JR; El-Osta A Oncogene; 2005 Dec; 24(54):8061-75. PubMed ID: 16091741 [TBL] [Abstract][Full Text] [Related]
14. Epigenetic therapies reach main street. Bates SE Clin Cancer Res; 2009 Jun; 15(12):3917. PubMed ID: 19528089 [No Abstract] [Full Text] [Related]
15. Epigenetic perspectives on cancer chemotherapy response. Liu MZ; McLeod HL; He FZ; Chen XP; Zhou HH; Shu Y; Zhang W Pharmacogenomics; 2014 Apr; 15(5):699-715. PubMed ID: 24798726 [TBL] [Abstract][Full Text] [Related]
16. Molecular basis of the anti-cancer effects of histone deacetylase inhibitors. Epping MT; Bernards R Int J Biochem Cell Biol; 2009 Jan; 41(1):16-20. PubMed ID: 18765293 [TBL] [Abstract][Full Text] [Related]
17. Epigenome: a new target in cancer therapy. Giacinti L; Vici P; Lopez M Clin Ter; 2008; 159(5):347-60. PubMed ID: 18998037 [TBL] [Abstract][Full Text] [Related]
18. Novel approaches on epigenetics. Papait R; Monti E; Bonapace IM Curr Opin Drug Discov Devel; 2009 Mar; 12(2):264-75. PubMed ID: 19333872 [TBL] [Abstract][Full Text] [Related]
19. Epi-drugs to fight cancer: from chemistry to cancer treatment, the road ahead. Mai A; Altucci L Int J Biochem Cell Biol; 2009 Jan; 41(1):199-213. PubMed ID: 18790076 [TBL] [Abstract][Full Text] [Related]
20. Translating epigenetics into an anticancer drug pipeline for solid tumors. Roukos DH Expert Rev Med Devices; 2011 Jul; 8(4):409-13. PubMed ID: 21728725 [No Abstract] [Full Text] [Related] [Next] [New Search]